Teligent
TLGT
#10190
Rank
ยฃ11.96 M
Marketcap
ยฃ0.13
Share price
-13.85%
Change (1 day)
1,497.55%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -ยฃ32.43 Million

According to Teligent's latest financial reports the company's current earnings are ยฃ46.29 Million. In 2020 the company made an earning of -ยฃ28.54 Million a decrease over its 2019 earnings that were of -ยฃ5.96 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-ยฃ32.43 Million13.66%
2020-ยฃ28.54 Million378.89%
2019-ยฃ5.96 Million-46.87%
2018-ยฃ11.22 Million10.47%
2017-ยฃ10.15 Million-637.49%
2016ยฃ1.88 M-179.64%
2015-ยฃ2.38 Million-181.72%
2014ยฃ2.9 M-4806.02%
2013-ยฃ0.07 Million-97.35%
2012-ยฃ2.33 Million6.23%
2011-ยฃ2.2 Million-18.59%
2010-ยฃ2.7 Million-11.37%
2009-ยฃ3.04 Million98.4%
2008-ยฃ1.54 Million156.15%
2007-ยฃ0.6 Million-59.36%
2006-ยฃ1.48 Million17.92%
2005-ยฃ1.25 Million37.7%
2004-ยฃ0.91 Million25.51%
2003-ยฃ0.73 Million-289.84%
2002ยฃ0.38 M-1605.88%
2001-ยฃ0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.12 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.49 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA